Gene: NFKB2
Official Full Name: nuclear factor kappa B subunit 2provided by HGNC
Gene Summary: This gene encodes a subunit of the transcription factor complex nuclear factor-kappa-B (NFkB). The NFkB complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The protein encoded by this gene can function as both a transcriptional activator or repressor depending on its dimerization partner. The p100 full-length protein is co-translationally processed into a p52 active form. Chromosomal rearrangements and translocations of this locus have been observed in B cell lymphomas, some of which may result in the formation of fusion proteins. There is a pseudogene for this gene on chromosome 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11031 | NFKB2 Knockout cell line (HeLa) | Human | NFKB2 | 1:3~1:6 | Negative | Online Inquiry |
KO11032 | NFKB2 Knockout cell line (HCT 116) | Human | NFKB2 | 1:2~1:4 | Negative | Online Inquiry |
KO11033 | NFKB2 Knockout cell line (HEK293) | Human | NFKB2 | 1:3~1:6 | Negative | Online Inquiry |
KO11034 | NFKB2 Knockout cell line (A549) | Human | NFKB2 | 1:3~1:4 | Negative | Online Inquiry |
NFKB2 Gene Knockout Cell Lines are specially engineered cellular models designed to facilitate in-depth studies of the NFKB2 gene, which encodes a crucial subunit of the nuclear factor-kappa B (NF-κB) signaling pathway. This product involves targeted gene editing techniques, such as CRISPR-Cas9, to effectively disrupt the NFKB2 gene's function, enabling researchers to explore its role in various biological processes, including inflammation, immunity, and cell proliferation.
The primary function of NFKB2 gene knockout cell lines is to serve as a versatile platform for investigating the consequences of NFKB2 loss-of-function. In normal physiology, the NF-κB pathway regulates gene expression in response to stressors or pathogens; by creating knockout models, scientists can analyze downstream effects on inflammatory cytokine production, cell survival, and apoptotic pathways. This provides essential insights into how dysregulation of NFKB2 contributes to diseases such as cancer, autoimmune disorders, and chronic inflammation.
The importance of these cell lines extends beyond academic curiosity, as they are pivotal in translating research findings into clinical applications. They can be used in drug discovery and screening, allowing researchers to assess the efficacy of novel therapeutics targeting the NF-κB pathway. Additionally, these models may assist in biomarker identification and validation for diseases linked to NF-κB signaling dysregulation.
One of the unique selling points of NFKB2 gene knockout cell lines is their specificity and reliability. These customized models offer a distinct advantage over traditional methods, such as pharmacological inhibitors, which may have off-target effects or variable efficacy. Researchers can attain reproducible results with a robust, genetically stable platform tailored to their experimental needs, reducing the time spent establishing and validating models.
For researchers and clinicians aiming to deepen their understanding of NF-κB signaling and its involvement in human diseases, NFKB2 gene knockout cell lines are an invaluable resource. They provide a clear pathway towards elucidating molecular mechanisms and developing targeted treatments. Our company boasts a strong track record in genetic engineering and cell line development, ensuring that we deliver high-quality, reliable products to accelerate your research and innovations in biomedicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.